PharmiWeb Recruiter Blog

• Novel non-viral gene delivery platform to help advance tissue repair following orthopaedic surgery
• Funding from Innovate UK’s Transforming Medicines Manufacturing programme supporting innovative technologies for intracellular drug delivery

London, UK, and Nottingham, UK, 31 August 2023: TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK, the UK’s innovation agency. The funding will support the development of the Company’s gene therapy in a powder, a non-viral gene delivery system to improve tissue regeneration following surgery. TherageniX will initially focus on orthopaedic applications, with the aim of improving the outcomes for patients undergoing bone grafting procedures.

Largest single investment in Crop Protection in Germany for 40 years / Focus on Environmental and Human Safety / State-of-the-art lab building and greenhouse / 5 floor main building; 28,000 m² gross floor area / R&D facility offers space for 200 employees / Early safety screens and A.I. help design the next generation of Crop Protection

• Powered by Sanofi, a new BioMed X research team will develop a computational platform designed to accelerate drug development.

Heidelberg, June 29, 2023. BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: “Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates” (VPE). The end goal of this research project is to develop a versatile computational platform that can predict the efficacy of first- or best-in-class drug candidates in virtual patient populations at unprecedented accuracy, thereby addressing one of the most critical bottlenecks of the pharmaceutical industry today: a 90% failure rate of new drug candidates during clinical development.

Caidya was honored at the CRO Leadership Awards held in Boston, MA at the end of June for their win in the Overall Capabilities category. The award is a recognition of Caidya’s outstanding global capabilities and the tireless work that the team does daily to fulfill our vision to ensure potential therapies have the best opportunity to reach patients in need.

Sanofi, Meningitis Research Foundation, and the Confederation of Meningitis Organisations ignite a global awareness initiative against meningitis with launch of The Meningitis Flag

Hiring and retaining talented entry-level professionals is crucial for the success of any life science company. These individuals can bring fresh perspectives and innovative ideas to your organisation. Investing in early talent is also essential for your succession planning, and means you’ll be nurturing top talent from the very start of their journeys. However, in a competitive job market, it can be challenging to attract and retain these individuals.

NEW BRUNSWICK, N.J., August 23, 2023 – Johnson & Johnson (NYSE: JNJ) today announced the final results of its previously announced offer to its shareholders to exchange their shares of Johnson & Johnson common stock for shares of Kenvue Inc. (NYSE: KVUE) (“Kenvue”) common stock owned by Johnson & Johnson. The exchange offer expired at 12:00 midnight, New York City time, at the end of the day on August 18, 2023.

Fraudulent candidates are individuals who intentionally deceive employers by misrepresenting their qualifications, skills, or experience during the job application process. In the life science industry, these candidates pose a significant threat to employers.

23 August 2023: Kadans Science Partner (“Kadans”) is set to welcome AviadoBio to its recently completed wet lab innovation and flexible workspace centre at 20 Water Street in Canary Wharf.

As employers in the life science industry, it’s essential to offer attractive employee benefits that can help attract and retain top talent. Whilst providing competitive salaries is undoubtedly important, there are other things you must do in order to stand out against your competitors, especially if you don’t have the budget to compete with the compensation packages being offered by industry leaders.